Functional Strength Training and Kinesiotaping, With and Without Proprioceptive Neuromuscular Fac… (NCT07191301) | Clinical Trial Compass
CompletedNot Applicable
Functional Strength Training and Kinesiotaping, With and Without Proprioceptive Neuromuscular Facilitation in Fibular (Peroneal) Neuropathy
Pakistan48 participantsStarted 2025-08-10
Plain-language summary
Fibular neuropathy frequently manifests as foot drop, muscle weakness, altered gait, and sensory loss, all of which severely reduce mobility and quality of life. There is still uncertainty regarding the efficacy of kinesio taping (KT), proprioceptive neuromuscular facilitation (PNF), and functional strength training (FST) in combination. Although PNF improves neuromuscular coordination, KT provides proprioceptive input, and FST increases strength and mobility, there are no set treatment guidelines and little research has compared these modalities. In order to contribute to evidence-based rehabilitation techniques for people with fibular neuropathy, this study attempts to assess whether adding PNF to FST and KT improves functional outcomes compared to FST and KT alone.
Who can participate
Age range
18 Years – 35 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* • Adults (18-35 years old) are diagnosed with fibular neuropathy due to trauma or compression.
* Patients with muscle weakness, impaired balance and abnormal gait.
* Both Male and female participants will be included.
* Patients who test positive to the drag or slap test will be considered positive if the patient have difficulty in lifting the forefoot while walking, leading to dragging of the toes or compensatory hip/knee movements.
Exclusion Criteria:
* • Recent foot or ankle surgery (\<6 months).
* Complete loss of nerve supply
* Severe musculoskeletal or neurological conditions (Amyotrophic lateral sclerosis, multiple sclerosis, myopathies, severe osteoarthritis, severe compression, progressive neuropathies, severe balance and fall risk, Guillain-Barré Syndrome (GBS) and peripheral vascular diseases).
* Allergies to Kinesio tape materials.
* Patients who are not psychologically fit such as those who have undergone trauma and patients with severe psychological disorders (major depressive disorder, PTSD, schizophrenia) will be excluded if they have had a diagnosis within the last 6 months.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in dorsiflexor muscle strength measured by Manual Muscle Grading (MMG)